Discovery

Scroll to explore

Scroll back top

GPCR target for metabolic diseases

22 November 2021

mGluR3 PAM

CXCR4 biased agonist

NPFFR antagonist

Multi-target collaboration for rare diseases

26 February 2020

Undisclosed GPCR targets